{"task_id": "a7be70207d7b8f21", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 264/464)", "text": "proach to Gram Stain, Culture, and Sensitivity\n253\n\n--- Page 275 ---\nAntibiotics\nMechanism\nGram positive\nGram negative\nAnaerobes Others\nRenal adjustments\nPenicillins\nPenicillin G 2\u20134 M units IV q4\u20136h\nBactericidal, cell wall synthesis inhibition and lysis\n++ Strep\nMeningococcus\n++\nSyphilis\nYes (dose + interval)\nPenicillin V 250\u2013500 mg PO TID/QID\n++ Strep\n++\nYes (dose + interval)\nCloxacillin/nafcillin/oxacillin 1\u20132 g IV q4\u20136h\n++S. aureus\nNo\nAmino-Penicillins\nAmpicillin 1\u20132 g IV q4\u20136h\nBactericidal, cell wall synthesis inhibition and lysis\n+++Strep/Entero\n+/\bH. flu, +/\bE. coli\nListeria\nYes (interval)\nAmoxicillin 250\u20131000 mg PO TID\n+++Strep/Entero\n+/\bH. flu, +/\bE. coli\nYes (interval)\nAmox/clavulanate 875/125 mg PO BID\n+++Strep/Entero\n++H. flu, E. coli\n+++\nYes (interval)\nAnti-pseudomonal Penicillins\nPiperacillin 3\u20134 g IV q4\u20136h\nBactericidal, cell wall synthesis inhibition and lysis\n++\n++Pseudo\n++\nYes (dose + interval)\nPip/tazo 3.375 g q6h\u20134.5 g IV q8h\n++Staph\n++Pseudo/H. flu\n+++\nYes (dose + interval)\nTicarcillin 3\u20134 g IV q4\u20136h\n++\n++Pseudo\n++\nYes (dose + interval)\nTcarcillin/clavulanate 3.1 g IV q4\u20136h\n++\n++Pseudo\n+++\nYes (dose + interval)\nMonobactam and Carbapenems\nAztreonam 1\u20132 g IV q6\u20138h\nBactericidal, cell wall synthesis inhibition and lysis\n+++Pseudo\n+++\nYes (dose)\nImipenem 500 mg IV q6h\n+++\n++Pseudo\n+++\nYes (dose + interval)\nMeropenem 1 g IV q8h\n++\n+++Pseudo\n+++\nYes (dose + interval)\nErtapenem 1 g IV q24h\n++\n++(no Pseudo)\n+++\nYes (dose)\nDoripenem 500 mg IV q8h\n++\n+++\n+++\nYes (dose + interval)\nFirst-Generation Cephalosporins\nCefazolin 1\u20132 g IV q8h\nBactericidal, cell wall synthesis inhibition and lysis\n+++\n+\nYes (interval)\nCephalexin 250\u20131000 mg PO QID\n+++\n+\nYes (interval)\nSecond-Generation Cephalosporins\nCefuroxime 750\u20131500 mg IV q8h\nBactericidal, cell wall synthesis inhibition and lysis\n++\n++\nYes (interval)\nCefuroxime 125\u2013500 mg PO BID\n++\n++\nYes (interval)\nCefprozil 250\u2013500 mg PO q12h\n++\n++\nYes (interval)\nCefaclor 250\u2013500 mg PO BID\n++\n++\nYes (interval)\nThird/Fourth Generation Cephal.\nCefoxitin 1\u20132 g IV q6\u20138h\nBactericidal, cell wall synthesis inhibition and lysis\n+++\n+++\n++\nYes (interval)\nCefotaxime 1\u20132 g IV q6\u20138h\n+++\n+++\nYes (interval)\nCeftriaxone 1\u20132 g IV q24h\n+++\n+++\nNo\nCeftazidime 1 g IV q8\u201312h\n+++\n+++Pseudo\nYes (interval)\nCefepime 1\u20132 g IV q12h\n+\n+++Pseudo\nYes (interval)\nCefixime 400 mg PO daily\n+\n++\nYes (interval)\nCeftobiprole 500 mg IV q8\u201312h\n+++MRSA\n+++\nYes (interval)\nAminoglycosides\nGentamicin 5\u20137 mg/kg IV q24h\nBactericidal, binds to 30S and 50S ribosomes\nEntero (syn)\n+Pseudo\nYes (dose + interval)\nTobramycin 5\u20137 mg/kg IV q24h\n+/\u2013Entero (syn)\n++Pseudo\nYes (dose + interval)\nAmikacin 7.5 mg/kg q12h\n+/\u2013Entero (syn)\n++Pseudo\nYes (dose + interval)\nStreptomycin 15 mg/kg IM or IV q24h\nEntero (syn)\n++Pseudo\nAFB, Plague\nYes (dose + interval)\nAntibiotics\n254\nAntibiotics", "text_length": 2813, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 264/464)", "type": "chunk", "chunk_index": 263, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.610474", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.611199", "status": "complete", "chunks_added": 2}